Zhibo Zhang

Title: Zhibo Zhang: Innovator in Pharmaceutical Compounds

Introduction

Zhibo Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds that serve as inhibitors for various biological targets. With a total of three patents to his name, Zhang's work is recognized for its potential impact on medical treatments.

Latest Patents

Zhibo Zhang's latest patents include a dihydropyrazole azepine compound that serves as an Akt inhibitor. This compound is specifically designed to inhibit the Akt pathway, which is crucial in various cellular processes. Another notable patent involves a series of analogs of 4H-pyrazolo[1,5-a]benzimidazole compounds that act as PARP inhibitors. These compounds are particularly important in cancer therapy, as they target the PARP enzyme involved in DNA repair mechanisms.

Career Highlights

Throughout his career, Zhibo Zhang has worked with several reputable organizations. He has been associated with Harbin Zhenbao Pharmaceutical Co., Ltd. and the Hubei Bio-pharmaceutical Industrial Technological Institute Inc. His work in these institutions has allowed him to advance his research and contribute to the development of new pharmaceutical solutions.

Collaborations

Zhibo Zhang has collaborated with notable colleagues in his field, including Yong Wang and Shuhui Chen. These collaborations have fostered a productive environment for innovation and research, leading to the successful development of his patented compounds.

Conclusion

Zhibo Zhang's contributions to pharmaceutical innovation highlight his role as a key inventor in the industry. His patents reflect a commitment to advancing medical science and improving therapeutic options for patients.